Clinical trial
An Exploration of the Effects of the Dopamine Agonist Pramipexole on Binge Antecedants, Binge Frequency, and Weight in Binge Eating Disorder
NCT01106053 is registered in ClinicalTrials.gov with Neuropsychiatric Research Institute, Fargo, North Dakota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploration of the Effects of the Dopamine Agonist Pramipexole on Binge Antecedants, Binge Frequency, and Weight in Binge Eating Disorder
- Lead sponsor
- Neuropsychiatric Research Institute, Fargo, North Dakota
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- April 30, 2010
- Completion date
- Not reported
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
binge eating disorder